Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Healthcare Drug Manufacturers - Major Cannabis
Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Aphria Inc.
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(2)
•••
Post by monarkaon Oct 16, 2020 8:54am
248 Views
Post# 31727218

Morningstar has published a new Analyst Article for APHA

Morningstar has published a new Analyst Article for APHA
APHRIA INC (APHA:NSQ, US)
4.80  0.00 (0.00%)    Volume: Above Average
Today Morningstar has published a new Analyst Article for APHA.

To access the report, sign in to your RBC Direct Investing account and go to the "Detailed Quote" page under the Quotes and Research tab. Select the "Research" sub-tab and click on "Read Full Report."
To view the PDF report, click on the "Download PDF" link.
 
MORNINGSTAR'S TAKE
New Morningstar Rating Strong Buy   Credit Rating --
Fair Value 8.04 USD   Economic Moat None
Consider Buy --    Stewardship Grade Standard
Consider Sell --    Morningstar Uncertainty Very High
 

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities